Designing Longevity
Skip to main content

Best Peptide Medicines for Weight Loss

Start with the reason for treatment and the exact form you’re considering. General weight care, treatment for a specific cause of obesity, and participation in a trial are different decisions.

Read more

The best access route depends on the medicine you and your clinician choose. We compare labeled uses and verified access for each form, with trial evidence and research-only listings clearly marked.

Sources reviewed

Our medicine picks by need

  • Best-supported for greater weight loss in this head-to-head trial

    Zepbound injection

    FDA-approved for the specified use

    Over 72 weeks, tirzepatide produced greater average weight loss than semaglutide at the highest doses participants could tolerate in adults with obesity without diabetes.

    The trial compared specific injection regimens. It did not test the 7.2 mg Wegovy injection or Wegovy tablets.

  • Best fit if you want an FDA-approved peptide pill

    Wegovy tablets

    FDA-approved for the specified use

    This semaglutide tablet has a labeled adult weight-management use and a placebo-controlled trial of the 25 mg tablet regimen.

    A separate study and prescribing instructions apply. The trial does not show that the tablet works as well as a particular injection.

  • Best-supported peptide option for diagnosed acquired hypothalamic obesity

    Imcivree injection

    FDA-approved for the specified use

    Imcivree has a specific FDA-approved use for patients aged 4 and older with acquired hypothalamic obesity. A randomized trial directly studied that condition.

    This pick is specific to the diagnosed cause. It does not apply to general obesity or grade the medicine for other labeled diagnoses.

Compare weight-management medicines

Start with the use that matches your situation. Each entry shows what the FDA label or the research covers.

Looking for Foundayo? It is an FDA-approved oral small-molecule medicine for eligible adults. Read the Foundayo guide.

Plan your next step

See a problem or outdated information? Tell us.